BIT Capital’s Cardlytics CDLX Stock Holding History

BIT Capital’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,522	Closed	-$4.63M	–	148
2021 Q3	$4.63M	Buy	+5,522	New	+$5.6M	0.27%	35

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT Capital's CDLX Position: Q4 2021 in Review

BIT Capital sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 5,522 shares — an estimated $4.63M sold.

BIT Capital first reported a position in CDLX in Q3 2021 and held it in 1 quarter. The position peaked at $4.63M in Q3 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

BIT Capital reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
BIT Capital sold 5,522 Cardlytics shares in Q4 2021, an estimated $4.63M.
BIT Capital first reported a position in Cardlytics in Q3 2021 and held it in 1 quarter.
BIT Capital's Cardlytics position peaked at $4.63M in Q3 2021.
163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on BIT Capital's 13F filing for Q4 2021, filed 12 Feb 2025.